Hepatologist and researcher at @UNCGastro, @UNCLiverCenter and @UNC_Lineberger w/ focus on #LiverCancer | @AmJGastro Deputy AE | opinions mine alone
Joined April 2012
- Tweets3.9K
- Following1.6K
- Followers4.2K
- Likes9.9K
Andrew Moon retweeted
Now is the best time in the history of cirrhosis care. And it will only get better.
This week we release the first set of guidelines on preventive care in cirrhosis in @AmJGastro @AmCollegeGastro
Open access: ovid.com/jnls/ajg/fulltext/1…
Andrew Moon retweeted
Together with my coauthors (Jennifer C. Lai, MD/MBA), we lay out the evidence based strategies that prevent decompensation, hospitalization, and death for the more than 2 million Americans living with cirrhosis. We also walk through how to implement these concepts in practice
Andrew Moon retweeted
ACG Clinical Guideline: Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes
📕 bit.ly/acg-polyposis-syndrom…
🎙️ bit.ly/ajg-podcast-polyposis
📄 bit.ly/acg-polyposis-26-high…
@GMankaney @burkegastrodoc @CarlKayMD @AndrewMMoon
Andrew Moon retweeted
🆕 ACG Guideline Highlights: Adenomatous Colorectal Polyposis Syndromes 🧬
▪️Germline testing triggers + MGPT panel
▪️FAP/AFAP/MAP surveillance intervals
▪️Gastric & duodenal (Spigelman) mgmt
Proud to have contributed concept & content
🔗bit.ly/acg-polyposis-syndrom…
Andrew Moon retweeted
More big funding news! Andrew Moon, MD, MPH, and Louise Henderson, PhD, were awarded $400,000 for their new study on the early detection of liver cancer in patients with advanced types of liver disease.
Congrats, Drs. Moon and Henderson! 🎉 news.unchealthcare.org/2026/…
ALT Headshot of Andrew Moon, MD, MPH.
ALT Headshot of Louise Henderson, PhD.
Andrew Moon retweeted
Congratulations to past AASLD Foundation awardee @AndrewMMoon on receiving new NIH funding to advance the early detection of #livercancer in patients with #MASLD.
We're proud to support researchers whose work is improving the future of liver health!
🔬 #AASLD members @AndrewMMoon and Louise Henderson, PhD of @UNC_Lineberger are advancing the future of #livercancer detection and treatment.
Their research aims to improve early liver cancer detection in patients with #MASLD and provides new evidence supporting external beam radiation therapy for patients with early-stage liver cancer.
Read more: bit.ly/4akDA6L.
Andrew Moon retweeted
🏥machine_perfusion (#MP) is increasingly being utilised for #DCD liver transplants.
In this #UNOS study from 2016 to 2025, we showed an accelerated, 7.8-fold increase in the use of DCD livers from donors ≥60 in the #MP_era, with a reduction of the median #waitlist #time from 112 to 62 days, and acceptable early graft survival.
@_ILTS_
@ESOTtransplant
@Transpl_Int
frontierspartnerships.org/jo…
So thrilled to see our collaborative publication with @tedradonc, @ma5RN and many others now online in @JCO_ASCO
These data from a large, multinational cohort provide further support for EBRT's role in the management of HCC.
ascopubs.org/doi/10.1200/JCO…
This opportunity and collaborative effort would not have been possible without the support of the @AmCollegeGastro North American International GI Training Grant which provided support for my travel/training in Barcelona
Andrew Moon retweeted
Major international IPD effort by @ma5RN @AndrewMMoon and @tedradonc crafting a great team to assess the survival of almost 5000 HCC patients treated with EBRT and stratified by BCLC stage. Best information available to consider EBRT in clinical practice
pubmed.ncbi.nlm.nih.gov/4213…
Andrew Moon retweeted
The Nurse expertise and knowledge as central players in the BCLC strategy for conventional care and research. pubmed.ncbi.nlm.nih.gov/4176… The strength of a team relies on all its members @gemmaiserte @nllarch @AndrewMMoon @ma5RN in @SeminLiverDis
Andrew Moon retweeted
Fantastic editorial board retreat for the @AmCollegeGastro @AmJGastro in beautiful Savannah.
Planning for next year, thinking hard about current challenges in academic publishing and, most importantly, discussing the benefits of coffee.
Andrew Moon retweeted
New ACG guidelines on hepatic encephalopathy March 2026 📌🧠
📸: journals.lww.com/ajg/fulltex…
Andrew Moon retweeted
⭐ Meet the 2026 Clinical Research Leadership Program #CRLP cohort!
These physician-scientists will receive training in clinical research management & convene w/ other #ACGInstitute programs at #LeadershipYOU in June 2026.
🎉Congrats!
#ACGfamily #FutureofGI @NeenaSAbrahamMD
Andrew Moon retweeted
Rural-Urban Disparities in Hepatocellular Carcinoma Deaths Are Driven by Hepatitis C-Related Hepatocellular Carcinoma
Moon, et al.
📕 doi.org/10.14309/ajg.0000000…
@AndrewMMoon @sasha_link @DavidMauroMD @MLongMD @JasmohanBajaj
Andrew Moon retweeted
Important updates on liver cancer epidemiology:
➡️60% diagnosed at early stage 👍
➡️Only 57% had cirrhosis diagnosed before HCC
➡️Y-90 most common first treatment
@DeptVetAffairs
sciencedirect.com/science/ar…
Andrew Moon retweeted
A BCLC systematic review/meta-analysis of OS of HCC patients with vasc invasion receiving treatment in @HEP_Journal Heterogeneity across cohorts prevents robust figures except with TARE that offers a a pooled 1-year OS of 34% (95%CI:2–48%) @hospitalclinic pubmed.ncbi.nlm.nih.gov/4139…
Congrats to Gabe Lupu from @UNCGastro for an incredible talk on LIRADS discrepancies at @AASLDtweets #TLM25
We need to improve adoption of LIRADS for liver nodules in patients with cirrhosis and HBV throughout the US
Andrew Moon retweeted
The BCLC 2025 update starts next Monday. We will have full room but virtual attendance is available. Worth to see the launch of the updated BCLC prognostic and treatment model for HCC @hospitalclinic @AEEHLiver @ILCAnews @EASLnews @AASLDtweets @ContraCancerEs @idibaps
Andrew Moon retweeted
Woohoo! The list is out 📜
Check out my near-exhaustive 🧵 of networking events at #ACG2025 🏜️
🎀 prime networking opportunities
🎀 socialise and have fun
🎀 events for whatever your interest
Bookmark and enjoy! 🔖
#GITwitter #FutureOfGI